Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Monograph Capital is an active life sciences-focused venture investor, not an operating biotech company itself. Its portfolio includes companies across modalities such as gene therapies, small molecules, antibody-based therapeutics, and enabling digital healthcare platforms. The firm builds and invests in biotech and healthtech companies at various clinical stages, ranging from preclinical to late-phase clinical trials[1][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Monograph Capital Partners.